Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 18 | 2020 | 46 | 3.690 |
Why?
|
Receptors, Progesterone | 46 | 2013 | 1392 | 3.370 |
Why?
|
Lactoferrin | 19 | 2008 | 81 | 2.730 |
Why?
|
Progesterone | 29 | 2013 | 513 | 2.070 |
Why?
|
Receptors, Steroid | 23 | 2018 | 286 | 2.020 |
Why?
|
Receptors, Thyroid Hormone | 12 | 2018 | 93 | 1.870 |
Why?
|
Mammary Glands, Animal | 21 | 2018 | 533 | 1.600 |
Why?
|
Nerve Tissue Proteins | 15 | 2018 | 1491 | 1.480 |
Why?
|
DNA-Binding Proteins | 25 | 2018 | 4821 | 1.290 |
Why?
|
Reproduction | 7 | 2003 | 253 | 1.060 |
Why?
|
Uterus | 15 | 2006 | 678 | 0.950 |
Why?
|
Dihydroergotamine | 2 | 2020 | 10 | 0.850 |
Why?
|
Mammary Glands, Human | 4 | 2007 | 184 | 0.790 |
Why?
|
Enhancer Elements, Genetic | 2 | 2020 | 467 | 0.740 |
Why?
|
Mice, Knockout | 34 | 2018 | 5710 | 0.730 |
Why?
|
Mammary Neoplasms, Experimental | 7 | 2018 | 494 | 0.700 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 11 | 2007 | 591 | 0.670 |
Why?
|
Transcription Factors | 20 | 2020 | 5270 | 0.650 |
Why?
|
Animals | 100 | 2020 | 59536 | 0.620 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 132 | 0.610 |
Why?
|
Vasoconstrictor Agents | 1 | 2018 | 151 | 0.610 |
Why?
|
Mice | 61 | 2020 | 34495 | 0.560 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2016 | 36 | 0.560 |
Why?
|
Cell Proliferation | 8 | 2020 | 7226 | 0.550 |
Why?
|
Dopamine | 13 | 2003 | 312 | 0.550 |
Why?
|
Morphogenesis | 3 | 2013 | 337 | 0.540 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 1399 | 0.530 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2020 | 810 | 0.520 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2020 | 6915 | 0.510 |
Why?
|
Hematopoietic Stem Cells | 3 | 2018 | 1242 | 0.510 |
Why?
|
Gene Expression Regulation | 19 | 2016 | 4053 | 0.500 |
Why?
|
Transcriptome | 3 | 2018 | 1859 | 0.500 |
Why?
|
Signal Transduction | 15 | 2020 | 11965 | 0.480 |
Why?
|
Tamoxifen | 2 | 2018 | 876 | 0.480 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2020 | 8873 | 0.480 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 669 | 0.470 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 14 | 2010 | 41 | 0.430 |
Why?
|
Ovary | 9 | 2006 | 668 | 0.420 |
Why?
|
Transcription, Genetic | 18 | 2018 | 3154 | 0.410 |
Why?
|
Sexual Behavior, Animal | 6 | 2006 | 65 | 0.410 |
Why?
|
Ovulation | 4 | 2010 | 107 | 0.400 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2018 | 2359 | 0.400 |
Why?
|
Mice, Inbred C57BL | 17 | 2015 | 6942 | 0.370 |
Why?
|
Estrogens | 11 | 2001 | 751 | 0.360 |
Why?
|
Mammary Neoplasms, Animal | 4 | 2007 | 221 | 0.350 |
Why?
|
Receptors, Estrogen | 12 | 2018 | 2086 | 0.340 |
Why?
|
Epithelium | 9 | 2013 | 720 | 0.340 |
Why?
|
Estradiol | 9 | 2013 | 748 | 0.330 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2018 | 3552 | 0.330 |
Why?
|
Respiratory Burst | 1 | 2008 | 23 | 0.320 |
Why?
|
Embryonic and Fetal Development | 2 | 1999 | 205 | 0.320 |
Why?
|
Gene Dosage | 1 | 2011 | 829 | 0.310 |
Why?
|
Mesencephalon | 4 | 2003 | 58 | 0.310 |
Why?
|
Protein Isoforms | 7 | 2003 | 842 | 0.300 |
Why?
|
Progestins | 1 | 2007 | 87 | 0.290 |
Why?
|
Cell Movement | 4 | 2008 | 2466 | 0.290 |
Why?
|
Iron | 6 | 2003 | 376 | 0.290 |
Why?
|
Cloning, Molecular | 15 | 1997 | 1213 | 0.280 |
Why?
|
Mice, Inbred BALB C | 8 | 2018 | 2314 | 0.280 |
Why?
|
Base Sequence | 22 | 2012 | 4917 | 0.270 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3821 | 0.270 |
Why?
|
DNA | 19 | 2003 | 2693 | 0.270 |
Why?
|
Neutrophils | 3 | 2008 | 835 | 0.270 |
Why?
|
Recombinant Proteins | 10 | 1998 | 2927 | 0.260 |
Why?
|
RNA, Messenger | 17 | 2016 | 6150 | 0.260 |
Why?
|
Genitalia, Female | 2 | 2005 | 68 | 0.250 |
Why?
|
Immunity, Mucosal | 2 | 2002 | 108 | 0.250 |
Why?
|
Chickens | 19 | 1993 | 523 | 0.240 |
Why?
|
Molecular Sequence Data | 20 | 2006 | 6089 | 0.230 |
Why?
|
Recombinant Fusion Proteins | 6 | 1997 | 1555 | 0.230 |
Why?
|
Myeloproliferative Disorders | 1 | 2011 | 767 | 0.230 |
Why?
|
Pyramidal Cells | 1 | 2004 | 168 | 0.230 |
Why?
|
Plasmids | 8 | 2016 | 837 | 0.230 |
Why?
|
Gene Expression | 9 | 2009 | 3570 | 0.210 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 941 | 0.210 |
Why?
|
Breast | 4 | 2007 | 1344 | 0.210 |
Why?
|
Semicircular Canals | 1 | 2002 | 22 | 0.210 |
Why?
|
Female | 51 | 2018 | 141928 | 0.210 |
Why?
|
Cell Division | 10 | 2009 | 2489 | 0.210 |
Why?
|
Embryo Implantation | 2 | 2002 | 278 | 0.200 |
Why?
|
Axons | 1 | 2004 | 403 | 0.200 |
Why?
|
Anti-Inflammatory Agents | 2 | 2002 | 461 | 0.200 |
Why?
|
Dermatitis | 1 | 2001 | 60 | 0.200 |
Why?
|
Cell Survival | 3 | 2009 | 3045 | 0.200 |
Why?
|
Genes | 7 | 1992 | 491 | 0.190 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2001 | 82 | 0.190 |
Why?
|
Breast Neoplasms | 6 | 2018 | 15694 | 0.180 |
Why?
|
Humans | 53 | 2020 | 261506 | 0.180 |
Why?
|
Protein Binding | 8 | 2016 | 3438 | 0.180 |
Why?
|
E1A-Associated p300 Protein | 1 | 2020 | 92 | 0.180 |
Why?
|
Blotting, Western | 10 | 2014 | 3536 | 0.170 |
Why?
|
Cells, Cultured | 8 | 2018 | 5637 | 0.170 |
Why?
|
Pregnancy | 13 | 2004 | 7573 | 0.170 |
Why?
|
Seizures | 1 | 2004 | 989 | 0.160 |
Why?
|
Neurons | 6 | 2003 | 2287 | 0.160 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 17 | 0.160 |
Why?
|
Hippocampus | 1 | 2004 | 915 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2015 | 1498 | 0.160 |
Why?
|
DNA Damage | 4 | 2018 | 1954 | 0.160 |
Why?
|
Promoter Regions, Genetic | 12 | 2009 | 3101 | 0.160 |
Why?
|
Luteinizing Hormone | 3 | 2010 | 165 | 0.160 |
Why?
|
Oncogenes | 2 | 2020 | 673 | 0.160 |
Why?
|
Cellular Reprogramming | 1 | 2020 | 189 | 0.150 |
Why?
|
Myelodysplastic Syndromes | 1 | 2011 | 2979 | 0.150 |
Why?
|
Immunity, Innate | 1 | 2002 | 677 | 0.150 |
Why?
|
Membrane Transport Proteins | 2 | 2012 | 244 | 0.150 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2016 | 1217 | 0.150 |
Why?
|
Apoptosis | 7 | 2018 | 7591 | 0.150 |
Why?
|
Intestinal Mucosa | 1 | 2003 | 1081 | 0.140 |
Why?
|
Gastrointestinal Diseases | 1 | 2001 | 589 | 0.140 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2016 | 518 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1997 | 127 | 0.140 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2016 | 45 | 0.140 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 2045 | 0.140 |
Why?
|
Tumor Cells, Cultured | 5 | 2018 | 5395 | 0.140 |
Why?
|
Pro-Opiomelanocortin | 1 | 1997 | 113 | 0.140 |
Why?
|
Amino Acid Sequence | 12 | 1997 | 4233 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2009 | 330 | 0.140 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 905 | 0.140 |
Why?
|
p300-CBP Transcription Factors | 1 | 2016 | 110 | 0.130 |
Why?
|
Amino Acid Motifs | 1 | 2016 | 392 | 0.130 |
Why?
|
Atherosclerosis | 3 | 2013 | 935 | 0.120 |
Why?
|
Inflammation | 3 | 2018 | 2522 | 0.120 |
Why?
|
Binding Sites | 8 | 1997 | 2171 | 0.120 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2015 | 116 | 0.120 |
Why?
|
Posture | 5 | 2006 | 215 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 1 | 2018 | 1064 | 0.120 |
Why?
|
Mice, SCID | 1 | 2018 | 1869 | 0.120 |
Why?
|
rac GTP-Binding Proteins | 1 | 2013 | 39 | 0.120 |
Why?
|
Disease Susceptibility | 2 | 2008 | 538 | 0.120 |
Why?
|
Cytoplasmic Granules | 1 | 2014 | 89 | 0.120 |
Why?
|
Ovariectomy | 5 | 2006 | 330 | 0.120 |
Why?
|
Mice, 129 Strain | 1 | 2013 | 170 | 0.110 |
Why?
|
Central Nervous System | 1 | 1996 | 436 | 0.110 |
Why?
|
Chromosome Mapping | 3 | 2016 | 1471 | 0.110 |
Why?
|
Cell Lineage | 1 | 2016 | 668 | 0.110 |
Why?
|
Mice, Inbred ICR | 3 | 1999 | 239 | 0.110 |
Why?
|
Early Growth Response Protein 1 | 2 | 2011 | 67 | 0.110 |
Why?
|
Ligands | 7 | 2006 | 995 | 0.110 |
Why?
|
Aspergillus oryzae | 1 | 1992 | 8 | 0.110 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 840 | 0.110 |
Why?
|
Mast Cells | 1 | 2014 | 223 | 0.110 |
Why?
|
Saccharomyces cerevisiae | 3 | 1993 | 621 | 0.110 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 1992 | 108 | 0.100 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 194 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2018 | 1129 | 0.100 |
Why?
|
Dendritic Cells | 1 | 1998 | 1085 | 0.100 |
Why?
|
Cell Compartmentation | 1 | 2011 | 76 | 0.100 |
Why?
|
Stem Cells | 1 | 1998 | 1213 | 0.100 |
Why?
|
Myeloid Progenitor Cells | 1 | 2011 | 49 | 0.100 |
Why?
|
Phenotype | 4 | 2011 | 6295 | 0.090 |
Why?
|
Mice, Nude | 1 | 2018 | 4307 | 0.090 |
Why?
|
Thymus Gland | 2 | 2003 | 294 | 0.090 |
Why?
|
Organ Specificity | 5 | 2006 | 699 | 0.090 |
Why?
|
Pregnancy, Animal | 2 | 2001 | 92 | 0.090 |
Why?
|
Cumulus Cells | 1 | 2010 | 44 | 0.090 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2010 | 44 | 0.090 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 2216 | 0.090 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1989 | 26 | 0.090 |
Why?
|
Gene Silencing | 1 | 2012 | 837 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 2508 | 0.090 |
Why?
|
Computational Biology | 1 | 2016 | 1271 | 0.090 |
Why?
|
Paracrine Communication | 1 | 2010 | 128 | 0.090 |
Why?
|
Transferrin | 2 | 2003 | 78 | 0.080 |
Why?
|
Ovarian Follicle | 1 | 2010 | 152 | 0.080 |
Why?
|
Mice, Inbred Strains | 4 | 2003 | 521 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 1992 | 862 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 612 | 0.080 |
Why?
|
Histones | 1 | 2016 | 1466 | 0.080 |
Why?
|
Epithelial Cells | 5 | 2007 | 1818 | 0.080 |
Why?
|
Blotting, Southern | 3 | 1992 | 406 | 0.080 |
Why?
|
Secretory Vesicles | 1 | 2008 | 39 | 0.080 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2008 | 182 | 0.080 |
Why?
|
Chloroquine | 1 | 2007 | 53 | 0.080 |
Why?
|
Mice, Mutant Strains | 5 | 2009 | 634 | 0.080 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2008 | 226 | 0.080 |
Why?
|
Lymph Nodes | 2 | 2000 | 2967 | 0.080 |
Why?
|
Peroxidase | 1 | 2008 | 132 | 0.080 |
Why?
|
Corpus Striatum | 2 | 2005 | 104 | 0.080 |
Why?
|
NADPH Oxidases | 1 | 2008 | 146 | 0.080 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 1270 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 2 | 2002 | 410 | 0.080 |
Why?
|
In Situ Hybridization | 3 | 2003 | 1037 | 0.070 |
Why?
|
Benzamides | 1 | 2012 | 1832 | 0.070 |
Why?
|
Hypothalamus | 3 | 2006 | 255 | 0.070 |
Why?
|
Benzazepines | 2 | 2006 | 108 | 0.070 |
Why?
|
Phagocytosis | 1 | 2008 | 260 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 1992 | 524 | 0.070 |
Why?
|
Structure-Activity Relationship | 4 | 2005 | 931 | 0.070 |
Why?
|
Estrous Cycle | 1 | 2006 | 37 | 0.070 |
Why?
|
Aspergillus | 3 | 1997 | 149 | 0.070 |
Why?
|
Consensus Sequence | 2 | 1997 | 117 | 0.070 |
Why?
|
Protein Kinases | 1 | 2011 | 874 | 0.070 |
Why?
|
Macrophages | 1 | 2013 | 1304 | 0.070 |
Why?
|
Multigene Family | 4 | 1997 | 425 | 0.070 |
Why?
|
Glycosylation | 2 | 1997 | 213 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 4 | 1992 | 354 | 0.070 |
Why?
|
Monocytes | 1 | 2010 | 788 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 1 | 2008 | 233 | 0.070 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2006 | 157 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 1996 | 2992 | 0.070 |
Why?
|
Immunohistochemistry | 7 | 2006 | 7548 | 0.070 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 14551 | 0.070 |
Why?
|
Leukocytes | 1 | 2008 | 422 | 0.070 |
Why?
|
Mifepristone | 1 | 2006 | 147 | 0.070 |
Why?
|
Pyridines | 1 | 2012 | 1244 | 0.070 |
Why?
|
Dopamine Agonists | 1 | 2006 | 85 | 0.070 |
Why?
|
Protein Biosynthesis | 3 | 1989 | 889 | 0.070 |
Why?
|
Genes, p53 | 2 | 2007 | 1090 | 0.070 |
Why?
|
Synovial Membrane | 2 | 2002 | 41 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2006 | 198 | 0.060 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2004 | 25 | 0.060 |
Why?
|
Mucins | 1 | 2006 | 285 | 0.060 |
Why?
|
Neurotransmitter Agents | 2 | 2003 | 159 | 0.060 |
Why?
|
Kainic Acid | 1 | 2004 | 32 | 0.060 |
Why?
|
Alleles | 1 | 2011 | 2437 | 0.060 |
Why?
|
Tissue Distribution | 3 | 2006 | 875 | 0.060 |
Why?
|
Cell Differentiation | 3 | 2008 | 4078 | 0.060 |
Why?
|
Rats, Inbred WF | 5 | 2002 | 22 | 0.060 |
Why?
|
Transfection | 9 | 2006 | 2944 | 0.060 |
Why?
|
Blast Crisis | 1 | 2007 | 557 | 0.060 |
Why?
|
Blotting, Northern | 5 | 2001 | 682 | 0.060 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1996 | 261 | 0.060 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 548 | 0.060 |
Why?
|
Introns | 2 | 1997 | 432 | 0.060 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 46 | 0.060 |
Why?
|
DNA Primers | 4 | 2012 | 1399 | 0.060 |
Why?
|
Wound Healing | 1 | 2009 | 815 | 0.060 |
Why?
|
Heat-Shock Proteins | 3 | 1991 | 311 | 0.060 |
Why?
|
Cell Line | 9 | 1998 | 5114 | 0.060 |
Why?
|
Animals, Suckling | 1 | 2003 | 54 | 0.060 |
Why?
|
Neuropeptides | 1 | 2003 | 154 | 0.050 |
Why?
|
RANK Ligand | 1 | 2003 | 119 | 0.050 |
Why?
|
Models, Biological | 5 | 2003 | 3254 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 2 | 1997 | 994 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 3639 | 0.050 |
Why?
|
Transcriptional Activation | 4 | 2006 | 1070 | 0.050 |
Why?
|
Milk | 1 | 2003 | 120 | 0.050 |
Why?
|
Cyclins | 2 | 2009 | 456 | 0.050 |
Why?
|
Rats | 7 | 2009 | 6086 | 0.050 |
Why?
|
Duodenum | 1 | 2003 | 149 | 0.050 |
Why?
|
Acute Disease | 1 | 2007 | 2422 | 0.050 |
Why?
|
Animals, Newborn | 2 | 2003 | 1338 | 0.050 |
Why?
|
Host-Parasite Interactions | 1 | 2002 | 62 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2002 | 1538 | 0.050 |
Why?
|
Down-Regulation | 1 | 2007 | 2074 | 0.050 |
Why?
|
Membrane Glycoproteins | 2 | 2003 | 1073 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2005 | 644 | 0.050 |
Why?
|
NF-kappa B | 2 | 2014 | 1549 | 0.050 |
Why?
|
Colforsin | 2 | 2001 | 59 | 0.050 |
Why?
|
Gene Deletion | 2 | 2015 | 1442 | 0.050 |
Why?
|
Disease Progression | 2 | 2011 | 6682 | 0.050 |
Why?
|
Exons | 2 | 1997 | 1328 | 0.050 |
Why?
|
Ligases | 1 | 2000 | 70 | 0.050 |
Why?
|
Crosses, Genetic | 1 | 2000 | 241 | 0.050 |
Why?
|
Postural Balance | 1 | 2002 | 151 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 769 | 0.050 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1999 | 8 | 0.050 |
Why?
|
Langerhans Cells | 1 | 2000 | 50 | 0.050 |
Why?
|
Safety | 1 | 2001 | 465 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2007 | 1823 | 0.040 |
Why?
|
Gene Targeting | 2 | 1998 | 292 | 0.040 |
Why?
|
Epidermis | 1 | 2000 | 188 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 1506 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2002 | 216 | 0.040 |
Why?
|
Fertility | 2 | 1999 | 336 | 0.040 |
Why?
|
Adenylyl Cyclases | 2 | 1997 | 87 | 0.040 |
Why?
|
Models, Animal | 1 | 2002 | 664 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1999 | 189 | 0.040 |
Why?
|
Adenoviridae | 3 | 2002 | 1459 | 0.040 |
Why?
|
Cytokines | 2 | 2014 | 2809 | 0.040 |
Why?
|
Biotechnology | 2 | 1997 | 63 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 3 | 1989 | 542 | 0.040 |
Why?
|
Flow Cytometry | 3 | 2013 | 3033 | 0.040 |
Why?
|
Blastocyst | 1 | 1999 | 124 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2005 | 2022 | 0.040 |
Why?
|
Respiratory System | 1 | 1999 | 125 | 0.040 |
Why?
|
Intestines | 1 | 2003 | 686 | 0.040 |
Why?
|
Response Elements | 2 | 2010 | 193 | 0.040 |
Why?
|
Anovulation | 1 | 1997 | 5 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1996 | 611 | 0.040 |
Why?
|
Uterine Diseases | 1 | 1997 | 40 | 0.040 |
Why?
|
Homeostasis | 1 | 2003 | 950 | 0.040 |
Why?
|
Activating Transcription Factor 1 | 1 | 1997 | 21 | 0.040 |
Why?
|
Exocrine Glands | 1 | 1997 | 15 | 0.040 |
Why?
|
Oviducts | 5 | 1989 | 149 | 0.040 |
Why?
|
Methylnitrosourea | 3 | 2002 | 46 | 0.040 |
Why?
|
Brain Chemistry | 2 | 1997 | 145 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 1487 | 0.040 |
Why?
|
Lung | 1 | 2008 | 3151 | 0.040 |
Why?
|
Embryonic Development | 1 | 1999 | 306 | 0.040 |
Why?
|
Male | 14 | 2015 | 123000 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 1997 | 97 | 0.040 |
Why?
|
Receptors, Dopamine D1 | 1 | 1997 | 79 | 0.040 |
Why?
|
Mutation | 5 | 2015 | 15179 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 1999 | 741 | 0.030 |
Why?
|
Phytic Acid | 1 | 1995 | 9 | 0.030 |
Why?
|
Glucan 1,4-alpha-Glucosidase | 1 | 1995 | 12 | 0.030 |
Why?
|
Interleukin-1 | 3 | 2002 | 461 | 0.030 |
Why?
|
Receptors, Dopamine | 2 | 1993 | 42 | 0.030 |
Why?
|
Oncogene Proteins | 1 | 1997 | 354 | 0.030 |
Why?
|
Acid Phosphatase | 1 | 1995 | 59 | 0.030 |
Why?
|
Gestational Age | 1 | 1999 | 1069 | 0.030 |
Why?
|
Tripartite Motif Proteins | 1 | 2015 | 55 | 0.030 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2015 | 42 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 1995 | 158 | 0.030 |
Why?
|
Epitopes | 2 | 1988 | 685 | 0.030 |
Why?
|
Ubiquitins | 2 | 1992 | 86 | 0.030 |
Why?
|
Coronary Vessels | 2 | 2010 | 665 | 0.030 |
Why?
|
Stromal Cells | 1 | 1998 | 825 | 0.030 |
Why?
|
Pituitary Neoplasms | 1 | 1997 | 203 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 1996 | 129 | 0.030 |
Why?
|
Genes, Reporter | 1 | 1997 | 798 | 0.030 |
Why?
|
Receptors, IgE | 1 | 2014 | 39 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2015 | 4143 | 0.030 |
Why?
|
Tryptases | 1 | 2014 | 48 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1995 | 585 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2015 | 854 | 0.030 |
Why?
|
Infertility, Female | 1 | 1996 | 217 | 0.030 |
Why?
|
Conalbumin | 1 | 1992 | 2 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2014 | 163 | 0.030 |
Why?
|
Genomic Library | 1 | 1992 | 41 | 0.030 |
Why?
|
Enzyme Activation | 1 | 1997 | 1764 | 0.030 |
Why?
|
Aspergillus nidulans | 1 | 1992 | 28 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1992 | 264 | 0.030 |
Why?
|
alpha-Amylases | 1 | 1992 | 20 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 1997 | 446 | 0.030 |
Why?
|
Chemokines | 1 | 2014 | 314 | 0.030 |
Why?
|
Estrogen Antagonists | 1 | 1993 | 184 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1992 | 97 | 0.030 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 2 | 2002 | 108 | 0.030 |
Why?
|
Cyclin D1 | 2 | 2009 | 576 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 2 | 2003 | 81 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2015 | 630 | 0.030 |
Why?
|
Parity | 2 | 2002 | 139 | 0.030 |
Why?
|
Dexamethasone | 1 | 1997 | 1450 | 0.030 |
Why?
|
Levodopa | 1 | 1992 | 92 | 0.030 |
Why?
|
Gene Library | 1 | 1992 | 294 | 0.030 |
Why?
|
Phosphorylation | 4 | 2009 | 4804 | 0.030 |
Why?
|
Ovalbumin | 1 | 1991 | 254 | 0.020 |
Why?
|
Escherichia coli | 2 | 1995 | 1203 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2015 | 549 | 0.020 |
Why?
|
Cattle | 1 | 1992 | 783 | 0.020 |
Why?
|
RNA Splicing | 1 | 1992 | 370 | 0.020 |
Why?
|
Steroids | 1 | 1992 | 356 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2010 | 53 | 0.020 |
Why?
|
Dinoprostone | 2 | 2002 | 208 | 0.020 |
Why?
|
Age Factors | 2 | 1999 | 5377 | 0.020 |
Why?
|
Molecular Weight | 4 | 1992 | 629 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 121 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 14289 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2014 | 943 | 0.020 |
Why?
|
Immunoenzyme Techniques | 2 | 2002 | 1165 | 0.020 |
Why?
|
Cyclin D2 | 1 | 2009 | 40 | 0.020 |
Why?
|
Liver | 1 | 1999 | 2961 | 0.020 |
Why?
|
E2F Transcription Factors | 1 | 2009 | 132 | 0.020 |
Why?
|
Protein Conformation | 2 | 1989 | 1258 | 0.020 |
Why?
|
Tunica Intima | 1 | 2009 | 117 | 0.020 |
Why?
|
Swine | 1 | 1992 | 1541 | 0.020 |
Why?
|
Brain | 2 | 1999 | 4113 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 1546 | 0.020 |
Why?
|
Sulfonamides | 1 | 1997 | 1823 | 0.020 |
Why?
|
Avidin | 1 | 1987 | 18 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2010 | 1008 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2009 | 335 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 3 | 1993 | 118 | 0.020 |
Why?
|
Serotonin | 2 | 1999 | 264 | 0.020 |
Why?
|
Helicobacter pylori | 1 | 1996 | 1295 | 0.020 |
Why?
|
Phosphoserine | 1 | 2006 | 107 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1992 | 3203 | 0.020 |
Why?
|
Myometrium | 1 | 2006 | 79 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2006 | 191 | 0.020 |
Why?
|
Mucin-1 | 1 | 2006 | 127 | 0.020 |
Why?
|
Trans-Activators | 1 | 1992 | 1555 | 0.020 |
Why?
|
Cross Reactions | 1 | 1986 | 266 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2005 | 53 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 891 | 0.020 |
Why?
|
Cytochromes c | 1 | 2005 | 118 | 0.020 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 430 | 0.020 |
Why?
|
Norepinephrine | 2 | 1999 | 272 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1987 | 402 | 0.020 |
Why?
|
Quinpirole | 2 | 1997 | 4 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2005 | 196 | 0.020 |
Why?
|
Hyperplasia | 2 | 1997 | 557 | 0.020 |
Why?
|
Species Specificity | 1 | 1986 | 777 | 0.020 |
Why?
|
Methamphetamine | 1 | 2005 | 61 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2003 | 7222 | 0.020 |
Why?
|
Cell Cycle | 1 | 2010 | 2084 | 0.020 |
Why?
|
Aorta | 1 | 2009 | 692 | 0.020 |
Why?
|
Mutagenesis | 1 | 2006 | 483 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 1988 | 4367 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 1443 | 0.020 |
Why?
|
alpha-Synuclein | 1 | 2005 | 118 | 0.020 |
Why?
|
Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 1 | 0.020 |
Why?
|
Homozygote | 2 | 1996 | 717 | 0.010 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 1 | 2003 | 17 | 0.010 |
Why?
|
Vesicular Monoamine Transport Proteins | 1 | 2003 | 16 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 639 | 0.010 |
Why?
|
Chimera | 2 | 1995 | 145 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2005 | 369 | 0.010 |
Why?
|
Bone Marrow | 1 | 2010 | 2358 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 621 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1994 | 3343 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 848 | 0.010 |
Why?
|
Perphenazine | 1 | 2001 | 5 | 0.010 |
Why?
|
Reproductive History | 1 | 2001 | 25 | 0.010 |
Why?
|
Ergolines | 2 | 1991 | 5 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2002 | 211 | 0.010 |
Why?
|
Ethers, Cyclic | 2 | 1991 | 16 | 0.010 |
Why?
|
Injections, Intralesional | 1 | 2002 | 164 | 0.010 |
Why?
|
Okadaic Acid | 2 | 1991 | 28 | 0.010 |
Why?
|
Ganciclovir | 1 | 2002 | 174 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 2002 | 193 | 0.010 |
Why?
|
Carcinogens | 1 | 2002 | 384 | 0.010 |
Why?
|
Oxazolone | 1 | 2000 | 5 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 260 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2001 | 32848 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 1991 | 220 | 0.010 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2001 | 342 | 0.010 |
Why?
|
Choline O-Acetyltransferase | 1 | 1999 | 19 | 0.010 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 1999 | 25 | 0.010 |
Why?
|
Knee Joint | 1 | 2001 | 161 | 0.010 |
Why?
|
Substantia Nigra | 1 | 1999 | 41 | 0.010 |
Why?
|
Dopamine Agents | 1 | 1999 | 38 | 0.010 |
Why?
|
Precipitin Tests | 2 | 1991 | 329 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2002 | 423 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 1999 | 155 | 0.010 |
Why?
|
Receptors, Interleukin-8A | 1 | 1999 | 16 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 1999 | 97 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1493 | 0.010 |
Why?
|
In Vitro Techniques | 2 | 1991 | 1618 | 0.010 |
Why?
|
Macrophage Activation | 1 | 1999 | 148 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2000 | 210 | 0.010 |
Why?
|
Cell Count | 1 | 1999 | 508 | 0.010 |
Why?
|
Diethylstilbestrol | 2 | 1989 | 109 | 0.010 |
Why?
|
Allergens | 1 | 2000 | 247 | 0.010 |
Why?
|
Genetic Vectors | 2 | 1997 | 1694 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2003 | 1143 | 0.010 |
Why?
|
Organ Size | 1 | 1999 | 690 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1999 | 269 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1997 | 191 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1999 | 309 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 1999 | 486 | 0.010 |
Why?
|
Carbachol | 1 | 1997 | 28 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 1099 | 0.010 |
Why?
|
Muscarinic Agonists | 1 | 1997 | 40 | 0.010 |
Why?
|
Prolactin | 1 | 1997 | 155 | 0.010 |
Why?
|
Pituitary Gland | 1 | 1997 | 150 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 2063 | 0.010 |
Why?
|
Follicle Stimulating Hormone | 1 | 1997 | 241 | 0.010 |
Why?
|
Receptors, Dopamine D2 | 1 | 1997 | 63 | 0.010 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 1997 | 167 | 0.010 |
Why?
|
Interleukin-8 | 1 | 1999 | 519 | 0.010 |
Why?
|
Isoquinolines | 1 | 1997 | 116 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1996 | 300 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 234 | 0.010 |
Why?
|
Endometritis | 1 | 1996 | 9 | 0.010 |
Why?
|
Copulation | 1 | 1995 | 9 | 0.010 |
Why?
|
Neuroimmunomodulation | 1 | 1996 | 66 | 0.010 |
Why?
|
Growth Substances | 1 | 1995 | 300 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2002 | 1230 | 0.010 |
Why?
|
Up-Regulation | 1 | 2001 | 2450 | 0.010 |
Why?
|
Decidua | 1 | 1995 | 154 | 0.010 |
Why?
|
Skin | 1 | 2000 | 1259 | 0.010 |
Why?
|
DNA Mutational Analysis | 2 | 1991 | 2283 | 0.010 |
Why?
|
Feedback | 1 | 1995 | 198 | 0.010 |
Why?
|
Antigens, CD | 1 | 1999 | 1385 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1997 | 875 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5178 | 0.010 |
Why?
|
Polyunsaturated Alkamides | 1 | 1993 | 35 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1999 | 1294 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1992 | 55 | 0.010 |
Why?
|
Sex Characteristics | 1 | 1995 | 417 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 1992 | 109 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1994 | 869 | 0.010 |
Why?
|
Bone and Bones | 1 | 1996 | 619 | 0.010 |
Why?
|
Coturnix | 1 | 1991 | 10 | 0.010 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1991 | 36 | 0.010 |
Why?
|
Incidence | 1 | 2002 | 5673 | 0.010 |
Why?
|
Isoproterenol | 1 | 1991 | 127 | 0.010 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 1 | 1991 | 28 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1997 | 686 | 0.010 |
Why?
|
Epinephrine | 1 | 1991 | 255 | 0.010 |
Why?
|
Pheochromocytoma | 1 | 1992 | 281 | 0.010 |
Why?
|
Solubility | 1 | 1990 | 242 | 0.010 |
Why?
|
HeLa Cells | 1 | 1993 | 1643 | 0.010 |
Why?
|
Action Potentials | 1 | 1992 | 560 | 0.010 |
Why?
|
Time Factors | 1 | 2003 | 12926 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2001 | 5159 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 1879 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 1993 | 803 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 1989 | 124 | 0.010 |
Why?
|
Reticulocytes | 1 | 1989 | 55 | 0.010 |
Why?
|
Cell Membrane | 1 | 1992 | 850 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1996 | 4938 | 0.010 |
Why?
|
Cosmids | 1 | 1987 | 40 | 0.000 |
Why?
|
RNA Caps | 1 | 1987 | 34 | 0.000 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1992 | 489 | 0.000 |
Why?
|
Phosphoproteins | 1 | 1993 | 1152 | 0.000 |
Why?
|
Hybrid Cells | 1 | 1987 | 128 | 0.000 |
Why?
|
Metaphase | 1 | 1987 | 107 | 0.000 |
Why?
|
DNA, Recombinant | 1 | 1987 | 121 | 0.000 |
Why?
|
Oncogene Proteins v-erbA | 1 | 1987 | 4 | 0.000 |
Why?
|
Rabbits | 1 | 1989 | 957 | 0.000 |
Why?
|
Retroviridae Proteins | 1 | 1987 | 20 | 0.000 |
Why?
|
Cell Line, Transformed | 1 | 1987 | 394 | 0.000 |
Why?
|
Cricetulus | 1 | 1987 | 205 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1986 | 117 | 0.000 |
Why?
|
Trypsin | 1 | 1986 | 140 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1999 | 3869 | 0.000 |
Why?
|
Cricetinae | 1 | 1987 | 706 | 0.000 |
Why?
|
Immunoblotting | 1 | 1987 | 886 | 0.000 |
Why?
|
Risk Factors | 1 | 2001 | 17523 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 2001 | 7789 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1986 | 1271 | 0.000 |
Why?
|